CME CME GROUP INC.

MIXED Impact: 2/10 ANALYST-UPGRADE
Processed 20d 16h ago SEC analyst-CME-tdcowen-20260114
13 firms acted on CME: Argus Research, TD Cowen, Deutsche Bank, Citigroup, UBS, Morgan Stanley, Raymond James, Citigroup, Redburn Atlantic, RBC Capital, TD Cowen, B of A Securities, JP Morgan
Final — all horizons settled through T+60d
CME ▲ +9.17% at T+60d
NEUTRAL call ✓ call won +9.17% · α vs SPY +9.81% · entry $275.15 → $300.39
Last close $246.38 (close Jun 18) · -10.46% from $275.15 entry
Entry anchored
Jan 14, 11:18 AM ET
via Databento tick
T+1d
-0.95%
call -0.95% · α -1.18%
$272.55
settled 5mo ago
T+5d
+2.24%
call +2.24% · α +2.47%
$281.32
settled 5mo ago
T+20d
+9.62%
call +9.62% · α +10.95%
$301.63
settled 4mo ago
T+60d
+9.17%
call +9.17% · α +9.81%
$300.39
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

TD Cowen upgraded CME Group Inc. to Buy from Hold, raising its price target to $305 from $290, implying 11.5% upside from the current $273.54. The upgrade is part of a broader cluster of 13 firms acting on CME, though the consensus remains mixed with 10 Buy-equivalent ratings, 8 Holds, and 3 Sells. The mean price target is $306.47, with a high of $353 and a low of $230. TD Cowen has a 56% accuracy rate on 1,801 calls with an average return of 3.4%, placing it near the middle of the pack. Over the past 30 days, no upgrades or downgrades were recorded, but EPS revisions for the current fiscal year show 3 upward revisions versus 11 downward, indicating some negative estimate pressure. Insider activity is mixed: CEO Terrence Duffy sold $7.75M worth of shares on May 15, while director William Shepard bought $418K on March 26. Institutional flows show a massive new $1.52B position from Norges Bank, offset by near-exits from Renaissance Technologies and Two Sigma. The short interest ratio is elevated at 55.3%, suggesting bearish positioning. The bottom line: TD Cowen's upgrade adds a bullish catalyst to a stock with mixed signals, but the high short interest and insider selling warrant caution.

Impact Score

Base Score
1/7
LLM Adjustment
+1
Final Score
2/10

Consensus & Targets

Buy / Strong Buy
10 (48%)
Hold
8
Sell / Strong Sell
3
Total Analysts
15
Mean PT
$306.47
Median PT
$316.00
High PT
$353.00
Low PT
$230.00
Current Price
$273.54
Implied Upside
+12%

The consensus on CME is mixed: 2 Strong Buy, 8 Buy, 8 Hold, 3 Sell, 0 Strong Sell, from 21 analysts. This gives a 48% Buy-equivalent ratio, 38% Hold, and 14% Sell, indicating no clear directional tilt.

Current price is $273.54. Mean target is $306.47, median $316, high $353, low $230. Implied upside to mean is 12.0%. TD Cowen's $305 target is slightly below the mean and median, placing it in the middle of the consensus range.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-04-23 Morgan Stanley maintain Overweight $353.00
2026-04-23 Barclays maintain Equal-Weight $316.00
2026-04-15 Piper Sandler maintain Overweight $329.00
2026-04-13 Barclays maintain Equal-Weight $343.00
2026-04-10 Morgan Stanley maintain Overweight $362.00
2026-04-08 Barclays maintain Equal-Weight $344.00
2026-03-04 Argus Research downgrade Hold
2026-02-05 JP Morgan maintain Underweight $266.00
2026-02-05 TD Cowen maintain Buy $328.00
2026-02-05 Barclays maintain Equal-Weight $312.00

Over the past 30 days, there have been 0 upgrades and 0 downgrades. EPS revisions for the current fiscal year show 3 upward revisions and 11 downward in the last 30 days, with the average EPS estimate rising slightly from $12.2376 to $12.26793. For the current quarter, there were 0 upward and 11 downward revisions, indicating near-term estimate pressure.

Firm Track Record — TD Cowen

TD Cowen accuracy: 56% on 1801 calls | avg return: 3.4%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 12 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
UBS 100% 4/4 3.1% top tier
RBC Capital 100% 6/6 7.8% top tier
Deutsche Bank 100% 5/5 6.7% top tier
Piper Sandler 89% 8/9 8.5% top tier
Morgan Stanley 88% 7/8 6.1% top tier
Keefe, Bruyette & Woods 75% 6/8 7.6% top tier
Barclays 71% 10/14 5.6% top tier
Oppenheimer 71% 5/7 3.6% top tier
Citigroup 60% 3/5 4.9% above average
Raymond James 50% 1/2 0.7% below average

TD Cowen has a 56% accuracy rate on 1,801 scored calls with an average return of 3.4%, ranking as average among firms covering CME. Top-tier firms include UBS (100% on 4 calls, avg return 3.1%), RBC Capital (100% on 6 calls, avg return 7.8%), and Piper Sandler (89% on 9 calls, avg return 8.5%). Bottom-tier firms include JP Morgan (0% on 6 calls, avg return 5.9%) and B of A Securities (0% on 4 calls, avg return 5.1%).

Earnings Estimates

Next earnings: Jul 21, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0y $12.27 $11.91 — $12.62 $7.0B ↑1 ↓0
+1q $2.97 $2.80 — $3.16 $1.7B ↑1 ↓0
0q $2.98 $2.88 — $3.10 $1.7B ↑0 ↓0
+1y $12.91 $11.85 — $13.61 $7.3B ↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
1 buys / 4 sells
Institutional
NORGES BANK — new
Institutional
RENAISSANCE TECHNOLOGIES LLC — near_exit (-91.4%)
Institutional
TWO SIGMA INVESTMENTS, LP — near_exit (-86.9%)
Short Interest
Short: 320,116 | Exempt: 73 | TRF Vol: 579,251 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)

Insider trades show a mix: CEO Terrence Duffy sold $7.75M on May 15, director Jonathan Marcus sold ~$2.13M on March 17, and director Hilda Piell sold $1.75M on May 18. Director William Shepard bought $418K on March 26. Institutional activity is divergent: Norges Bank initiated a massive $1.52B position, while Renaissance Technologies and Two Sigma nearly exited. Short interest ratio is 55.3%, indicating heavy bearish positioning. The insider selling and high short interest diverge from the bullish analyst signal, creating a mixed picture.

Actionable Insight

TD Cowen's upgrade provides a bullish catalyst, but the high short interest ratio and insider selling suggest caution. Traders should watch for a short squeeze if earnings on July 21 beat expectations, but the downward EPS revisions argue for a wait-and-see approach.

Documents Analyzed

Report based on filing metadata.

11 reports for CME
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +17.30%Mar 12, 2026
Filters
Rows
Reports for CME — sortable, filterable
Type Now
Jun 18, 2026
2d ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$247.38 awaiting T+1awaiting T+1$246.38 (−0.40%)
Jun 17, 2026
3d ago
8-K
NEUTRAL ★ 4/10
$252.54 $246.38▼ −2.44%▼ −3.22%$246.38 (−2.44%)
Jun 11, 2026
9d ago
ANALYST-UPGRADE
BULLISH ★ 1/10
$269.53 $266.08▼ −1.28%▼ −3.04%$246.38 (−8.59%)
May 31, 2026
20d ago
ANALYST-UPGRADE
MIXED ★ 2/10
$275.15 $272.55▼ −0.95%▼ −1.18%$246.38 (−10.46%)
May 19, 2026
4w ago
DEFA14A
NEUTRAL ★ 4/10
$290.04 $289.31▼ −0.25%▼ −0.45%$246.38 (−15.05%)
May 19, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$290.04 $289.31▼ −0.25%▼ −0.45%$246.38 (−15.05%)
Apr 22, 2026
8w ago
8-K
BEARISH ★ 6/10
$285.58 $285.29▲ +0.10%▼ −0.29%$246.38 (+13.73%)
Mar 27, 2026
12w ago
Court Ruling
BULLISH ★ 4/10
$293.69 $297.49▲ +1.29%▲ +1.65%$246.38 (−16.11%)
Mar 23, 2026
12w ago
DEFA14A
NEUTRAL ★ 3/10
$302.56 $293.92▼ −2.86%▼ −3.42%$246.38 (−18.57%)
Mar 12, 2026
14w ago
Insider Cluster
BEARISH ★ 6/10
$311.25 $311.41▼ −0.05%▼ −0.65%$246.38 (+20.84%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (27h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access